Supplementary Materials

 

Pulim, V., Bienkowska, J., Berger B., LTHREADER: PREDICTION OF LIGAND-RECEPTOR INTERACTIONS USING LOCALIZED THREADING. Pacific Symposium on Biocomputing 12:64-75 (2007).

 

 

 

Table S1: Datasets: Long-chain 4-helical bundle and TNF-like cytokine ligands and receptor

 

4-Helical Bundle Cytokines

Abbreviation

Name

Ligands

EPO

Erythropoietin

CSF3

Colony stimulating factor 3

GH

Growth hormone

IL6

Interleukin 6

LIF

Leukemia inhibitory factor

OSM

Oncostatin M

CNTF

Ciliary neurotrophic factor

IL23

Interleukin 23

IL12

Interleukin 12

LEP

Leptin

PRL

Prolactin

Receptors

EPOR

Erythropoietin receptor

CSF3R

Colony stimulating factor 3 receptor

GHR

Growth hormone receptor

GP130

GP130

IL12R

Interleukin 12 receptor

LEPR

Leptin receptor

PRLR

Prolactin receptor

TNF-Like Cytokines

Abbreviation

Name

Ligands

TNFSF1

Lymphotoxin alpha (LTA)

TNFSF2

Tumor necrosis factor (TNF)

TNFSF3

Lymphotoxin beta (LTB)

TNFSF4

OX40 antigen ligand (OX40L)

TNFSF5

CD40 antigen ligand (CD40L)

TNFSF6

Fas antigen ligand (FASL)

TNFSF10

TNF-related apoptosis inducing ligand (TRAIL)

TNFSF11

Receptor activator of NF-kappa-B ligand (RANKL)

TNFSF12

TNF-related weak inducer of apoptosis (TWEAK)

TNFSF13

APOL-related leukocyte expressed ligand 2 (APRIL)

TNFSF13B

B-cell activating factor (BAFF)

TNFSF15

TNF ligand-related molecule 1 (TL1A)

Receptors

TNFRSF1A

Tumor necrosis factor receptor 1 (TNFR1)

TNFRSF1B

Tumor necrosis factor receptor 2 (TNFR2)

TNFRSF4

OX40 antigen (OX40)

TNFRSF5

CD40 antigen (CD40)

TNFRSF6

Fas antigen (FAS)

TNFRSF6B

Decoy receptor 3 (DcR3)

TNFRSF10B

TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2)

TNFRSF11A

Receptor activator of NF-kappaB (RANK)

TNFRSF11B

Osteoprotegerin (OPG)

TNFRSF12

DR3

TNFRSF12A

Type I transmembrane protein Fn14

TNFRSF13B

Transmembrane activator and CAML interactor (TACI)

TNFRSF13C

B-cell activating factor receptor (BAFFR)

TNFRSF17

B-cell maturation factor (BCMA)

LTBR

Lymphotoxin B receptor

 

 

 

Table S2: Datasets: Template complexes

 

4-Helical Bundle Cytokine Complexes

Ligand

Receptor

PDB ID

CSF3

CSF3R

1cd9

EPO

EPOR

1cn4

GH

GHR

1hwg

IL6

GP130

1p9m

LIF

GP130

1pvh

TNF-Like Cytokine Complexes

Ligand

Receptor

PDB ID

TNFSF10

TNFRSF10B

1dog

TNFSF13

TNFRSF13B

1xu1

TNFSF13

TNFRSF17

1xu2

TNFSF13B

TNFRSF13C

1oqe

TNFSF13B

TNFRSF17

1oqd

 

 

 

Table S3: Comparison of single and combined scoring methods using 1-fold cross validation on experimentally confirmed binding and non-binding pairs of ligands and receptors. “YES” indicates the method predicted the pair binds, “NO” that the pair does not bind. Green shading indicates that the prediction agrees with experimental data; red that it does not. See Section 3.3 for definitions of the CM, SP, FF and CR scoring methods.  The significance of predicting interactions is equals to 1 minus the frequency of predicting interactions between pairs using randomized interaction surfaces.

 

4-Helical Bundle Cytokines

Ligand

Receptor

Binding?

Binding Pairs

Exp

CM

SP

FF

CR

All

EPO

EPOR

YES

NO

YES

YES

NO

YES

CSF3

CSF3R

YES

NO

YES

NO

YES

NO

GH

GHR

YES

YES

YES

NO

YES

YES

IL6

GP130

YES

YES

NO

NO

YES

YES

LIF

GP130

YES

NO

NO

YES

YES

YES

OSM

GP130

YES

YES

YES

NO

NO

YES

CNTF

GP130

YES

YES

YES

YES

YES

YES

CTF1

GP130

YES

YES

YES

NO

NO

YES

IL23

IL12R

YES

YES

YES

NO

YES

YES

IL12

IL12R

YES

YES

NO

NO

YES

YES

LEP

LEPR

YES

NO

NO

YES

NO

NO

PRL

PRLR

YES

NO

YES

NO

NO

NO

Non-Binding Pairs

 

IL6

EPOR

NO

NO

NO

NO

NO

NO

IL6

CSF3R

NO

YES

YES

NO

NO

YES

CSF3

EPOR

NO

NO

NO

NO

NO

NO

LEP

GHR

NO

NO

NO

NO

YES

NO

OSM

CSF3R

NO

NO

YES

NO

YES

NO

LEP

GP130

NO

NO

NO

NO

YES

NO

GH

GP130

NO

NO

YES

NO

YES

NO

EPO

GP130

NO

NO

YES

NO

NO

NO

IL12

GP130

NO

NO

YES

NO

NO

NO

IL23

GP130

NO

NO

YES

NO

NO

NO

IL12

EPOR

NO

NO

NO

NO

NO

NO

IL23

EPOR

NO

NO

NO

NO

NO

NO

IL6

PRLR

NO

NO

YES

NO

NO

YES

IL12

LEPR

NO

NO

NO

NO

YES

NO

Sensitivity

58%

67%

33%

50%

75%

Specificity

93%

50%

100%

64%

86%

Significance

 

 

 

 

0.62

TNF-Like Cytokines

Ligand

Receptor

Binding?  

Binding Pairs

Exp

CM

SP

FF

CR

All

SF1

RSF1A

YES

NO

NO

NO

YES

YES

SF1

RSF1B

YES

NO

NO

NO

NO

YES

SF1

RSF14

YES

NO

NO

NO

YES

YES

SF2

RSF1A

YES

NO

NO

NO

YES

YES

SF2

RSF1B

YES

NO

NO

YES

NO

YES

SF3

RSF1A

YES

NO

YES

NO

NO

NO

SF3

RSF1B

YES

YES

YES

NO

YES

YES

SF3

LTBR

YES

YES

NO

NO

NO

YES

SF4

RSF4

YES

NO

NO

NO

YES

YES

SF5

RSF5

YES

NO

YES

NO

NO

NO

SF6

RSF6

YES

NO

NO

YES

YES

YES

SF6

RSF6B

YES

NO

NO

YES

YES

YES

SF10

RSF11B

YES

NO

NO

NO

NO

YES

SF11

RSF11A

YES

NO

YES

NO

NO

NO

SF11

RSF11B

YES

NO

YES

NO

NO

YES

SF12

RSF12A

YES

NO

NO

YES

YES

YES

SF13

RSF17

YES

NO

NO

NO

YES

NO

SF13B

RSF17

YES

NO

NO

NO

YES

NO

SF15

RSF6B

YES

NO

NO

YES

NO

NO

SF15

RSF12

YES

NO

YES

YES

YES

YES

Non-Binding Pairs

 

SF1

LTBR

NO

YES

YES

NO

NO

NO

SF1

RSF4

NO

YES

NO

NO

YES

YES

SF1

RSF5

NO

YES

YES

NO

NO

YES

SF2

RSF6

NO

NO

NO

NO

YES

NO

SF2

RSF6B

NO

YES

YES

NO

YES

YES

SF3

RSF11A

NO

YES

YES

NO

NO

NO

SF3

RSF11B

NO

NO

YES

NO

YES

NO

SF3

RSF12A

NO

NO

NO

NO

YES

NO

SF4

RSF17

NO

YES

NO

NO

YES

YES

SF5

RSF6B

NO

YES

NO

NO

NO

NO

SF6

RSF12

NO

NO

YES

NO

YES

YES

SF6

LTBR

NO

YES

YES

YES

NO

NO

SF10

RSF4

NO

YES

YES

NO

YES

NO

SF11

RSF5

NO

YES

YES

NO

NO

NO

SF11

RSF6

NO

YES

YES

YES

YES

YES

SF12

RSF6B

NO

NO

YES

YES

YES

YES

SF13

RSF11A

NO

NO

YES

YES

YES

NO

SF13B

RSF11B

NO

YES

YES

NO

YES

NO

SF15

RSF12A

NO

YES

NO

YES

YES

YES

SF15

RSF17

NO

NO

NO

YES

YES

YES

Sensitivity 

 

 10%

 30%

 30%

 55%

 70%

Specificity 

 

 35%

 35%

 70%

 30%

 55%

Significance 

 

 

 

 

 

0.81

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table S4: Comparison of sensitivity and specificity values for raw versus normalized scores for both the standalone CM and combined methods.

 

 

Raw

Normalized

CM Sensitivity

33%

58%

CM Specificity

57%

93%

Combined Sensitivity

33%

75%

Combined Specificity

50%

86%

 

 

 

Table S5:

 

Query Ligand-Receptor Pair

Template Complex

% similarity of query ligand to template ligand

% of interacting residue pairs correctly identified

(RAPTOR)

% of interacting residues correctly identified

(LTHREADER)

GH-GHR

IL6-GP130

23

33

53

GH-GHR

EPO-EPOR

15

30

55

GH-GHR

CSF3-CSF3R

20

31

63

EPO-EPOR

IL6-GP130

24

29

51

EPO-EPOR

GH-GHR

25

44

43

EPO-EPOR

CSF3-CSF3R

18

31

58

IL6-GP130

GH-GHR

22

28

52

IL6-GP130

EPO-EPOR

17

40

63

IL6-GP130

CSF3-CSF3R

21

42

66

CSF3-CSF3R

IL6-GP130

24

51

57

CSF3-CSF3R

EPO-EPOR

19

33

61

CSF3-CSF3R

GH-GHR

25

32

52

Average

21

35

56

 

Table S6:

 

Query Ligand-Receptor Pair

Template Complex

% similarity of query receptor to template receptor

% of interacting residue pairs correctly identified

(RAPTOR)

% of interacting residues correctly identified

(LTHREADER)

TNFSF13B-TNFRSF17

TNFSF13-TNFRSF13B

23

41

68

TNFSF13B-TNFRSF17

TNFSF10-TNFRSF10B

16

30

55

TNFSF13B-TNFRSF17

TNFSF13B-TNFRSF13C

39

60

82

TNFSF13B-TNFRSF13C

TNFSF13-TNFRSF13B

29

35

65

TNFSF13B-TNFRSF13C

TNFSF10-TNFRSF10B

18

25

45

TNFSF13B-TNFRSF13C

TNFSF13B-TNFRSF17

39

54

66

TNFSF10-TNFRSF10B

TNFSF13-TNFRSF13B

29

56

54

TNFSF10-TNFRSF10B

TNFSF13B-TNFRSF17

16

32

58

TNFSF10-TNFRSF10B

TNFSF13B-TNFRSF13C

18

42

38

TNFSF13-TNFRSF13B

TNFSF13B-TNFRSF17

23

56

74

TNFSF13-TNFRSF13B

TNFSF10-TNFRSF10B

29

40

62

TNFSF13-TNFRSF13B

TNFSF13B-TNFRSF13C

29

45

84

Average

25

43

63